AI drug discovery company

Protillion Biosciences

Data as of .

Company facts

Latest funding round

Round
Series A
Date
Dec 19, 2022
Amount
$18M
Lead investor
ARCH Venture Partners and Illumina Ventures

ConfirmedSource for the latest round (opens in new tab)

Drug discovery partners

1 pharma. Pharma here means a company with approved products and roughly $1B or more in annual revenue.

Recent news

  • Discovery collaboration and license with Merck & Co. ($510M total potential (upfront not disclosed))

    ConfirmedSource (opens in new tab)

  • Appoints Robert Hollingsworth as chief scientific officer

    ConfirmedSource (opens in new tab)

Confirmed means the company, a partner or a filing said it. Reported means a third party said it. This section sits outside the Pharma AI Tracker.

Spot an error? Tell me and I'll fix it.